Next, we verified the factors derived from tumor cells in HT29 and HCT116 colon cancer cells, and comfirmed that CYP19A1 inhibition significantly reduced PD-L1, IL-6, and TGF-β expression in tumor cells (Fig. 7B–D). Here, CYP19A1 is linked to malignant colon neoplasm.